UPDATE: Teva Pharmaceutical Reports Upbeat Q2 Profit

Teva Pharmaceutical Industries Ltd TEVA reported upbeat quarterly earnings. TEVA reported its Q2 non-GAAP net income at $984 million, up from $981 million, in the year-ago period. Its earnings on a non-GAAP basis came in at $1.10 per share, up from $1.08 per share. Analysts were expecting earnings of $1.08 per share. Its net sales surged 11% to $4.2 billion. Teva announced its plans to pay a quarterly dividend of 23.5 cents on August 18. TEVA shares dropped 1.03% to $46.31 in pre-market trading.